1. Home
  2. TTEK vs CORT Comparison

TTEK vs CORT Comparison

Compare TTEK & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tetra Tech Inc.

TTEK

Tetra Tech Inc.

N/A

Current Price

$40.75

Market Cap

10.1B

ML Signal

N/A

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$73.56

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TTEK
CORT
Founded
1966
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1B
9.7B
IPO Year
1995
2001

Fundamental Metrics

Financial Performance
Metric
TTEK
CORT
Price
$40.75
$73.56
Analyst Decision
Buy
Buy
Analyst Count
8
5
Target Price
$40.17
★ $142.60
AVG Volume (30 Days)
★ 2.1M
1.1M
Earning Date
11-11-2026
11-03-2026
Dividend Yield
★ 0.70%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 1.18
1.13
Revenue
★ $2,964,148,000.00
$761,407,000.00
Revenue This Year
N/A
$52.09
Revenue Next Year
$2.80
$44.73
P/E Ratio
★ $34.78
$65.61
Revenue Growth
7.66
★ 12.79
52 Week Low
$25.81
$28.66
52 Week High
$43.14
$126.38

Technical Indicators

Market Signals
Indicator
TTEK
CORT
Relative Strength Index (RSI) 73.24 24.69
Support Level $30.10 $30.24
Resistance Level $43.14 $122.93
Average True Range (ATR) 1.15 6.48
MACD 0.36 -1.61
Stochastic Oscillator 84.02 5.25

Price Performance

Historical Comparison
TTEK
CORT

About TTEK Tetra Tech Inc.

Tetra Tech Inc provides consulting and engineering services for environmental, infrastructure, resource management, energy, and international development markets. It specializes in providing water-related services for public and private clients. It designs infrastructure, facilities, and other structures with complex plans and resource management. it has two reportable segments. Its Government Services Group (GSG) segment includes activities with U.S. government clients (federal, state and local) and activities with development agencies world-wide. Commercial/International Services Group (CIG) segment, which derives maximum revenue, includes activities with U.S. commercial clients and international clients other than development agencies.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: